clarithromycin has been researched along with Hospital-Acquired Condition in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheon, JH; Kim, JH; Kim, TI; Kim, WH; Lee, SK; Lee, YC | 1 |
Pfister, HW; Suessmair, C; Wagner, J | 1 |
Cho, WY; Choi, IJ; Jung, HC; Keum, B; Kim, JG; Kim, SG; Lee, JH; Lee, YC; Park, BJ; Park, SK; Song, HJ | 1 |
De Schepper, J; De Schutter, I; De Wachter, E; Malfroot, A; Vanbesien, J | 1 |
Delpierre, S; Karoubi, E; Lacaille, S; Leclercq, V; Legrain, S | 1 |
Kim, WJ; Oh, CH; Ryu, HJ; Song, HJ | 1 |
2 trial(s) available for clarithromycin and Hospital-Acquired Condition
Article | Year |
---|---|
Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Iatrogenic Disease; Lansoprazole; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2008 |
Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iatrogenic Disease; Lansoprazole; Male; Middle Aged; Prospective Studies; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2013 |
4 other study(ies) available for clarithromycin and Hospital-Acquired Condition
Article | Year |
---|---|
Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Contraindications; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Energy Metabolism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iatrogenic Disease; Muscle Weakness; Muscle, Skeletal; Rhabdomyolysis; Risk Factors; Simvastatin | 2009 |
Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchodilator Agents; Budesonide; Clarithromycin; Cushing Syndrome; Cystic Fibrosis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Fatal Outcome; Female; Humans; Iatrogenic Disease; Infant, Newborn; Itraconazole; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous | 2003 |
[Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimanic Agents; Bipolar Disorder; Brain Diseases; Bronchitis; Carbamazepine; Clarithromycin; Drug Interactions; Electroencephalography; Humans; Iatrogenic Disease; Male; Time Factors | 2005 |
Iatrogenic Mycobacterium abscessus infection associated with acupuncture: clinical manifestations and its treatment.
Topics: Acupuncture Therapy; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Iatrogenic Disease; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Time Factors; Treatment Outcome | 2005 |